Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.

Arundhathi A, Chuang WH, Chen JK, Wang SE, Shyr YM, Chen JY, Liao WN, Chen HW, Teng YM, Pai CC, Wang CH.

Oncotarget. 2016 Jul 13. doi: 10.18632/oncotarget.10583. [Epub ahead of print]

2.

The spliceosome-associated protein Nrl1 suppresses homologous recombination-dependent R-loop formation in fission yeast.

Aronica L, Kasparek T, Ruchman D, Marquez Y, Cipak L, Cipakova I, Anrather D, Mikolaskova B, Radtke M, Sarkar S, Pai CC, Blaikley E, Walker C, Shen KF, Schroeder R, Barta A, Forsburg SL, Humphrey TC.

Nucleic Acids Res. 2016 Feb 29;44(4):1703-17. doi: 10.1093/nar/gkv1473.

3.

Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.

Stolfi JL, Pai CC, Murphy WJ.

FEBS J. 2016 May;283(9):1595-606. doi: 10.1111/febs.13612. Review.

PMID:
26640088
4.

Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.

Pfister SX, Markkanen E, Jiang Y, Sarkar S, Woodcock M, Orlando G, Mavrommati I, Pai CC, Zalmas LP, Drobnitzky N, Dianov GL, Verrill C, Macaulay VM, Ying S, La Thangue NB, D'Angiolella V, Ryan AJ, Humphrey TC.

Cancer Cell. 2015 Nov 9;28(5):557-68.

5.

Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice.

Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ.

J Exp Med. 2014 Nov 17;211(12):2373-83. doi: 10.1084/jem.20140116.

6.

Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.

Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1899-904. doi: 10.1016/j.bbmt.2014.07.022.

7.

Treatment of chronic graft-versus-host disease with bortezomib.

Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M.

Blood. 2014 Sep 4;124(10):1677-88. doi: 10.1182/blood-2014-02-554279.

8.

A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice.

Pai CC, Deegan RS, Subramanian L, Gal C, Sarkar S, Blaikley EJ, Walker C, Hulme L, Bernhard E, Codlin S, Bähler J, Allshire R, Whitehall S, Humphrey TC.

Nat Commun. 2014 Jun 9;5:4091. doi: 10.1038/ncomms5091.

9.

The DNA damage checkpoint pathway promotes extensive resection and nucleotide synthesis to facilitate homologous recombination repair and genome stability in fission yeast.

Blaikley EJ, Tinline-Purvis H, Kasparek TR, Marguerat S, Sarkar S, Hulme L, Hussey S, Wee BY, Deegan RS, Walker CA, Pai CC, Bähler J, Nakagawa T, Humphrey TC.

Nucleic Acids Res. 2014 May;42(9):5644-56. doi: 10.1093/nar/gku190.

10.

IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.

Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ.

J Immunol. 2012 Aug 15;189(4):2033-42. doi: 10.4049/jimmunol.1102853.

11.

Conditional inactivation of replication proteins in fission yeast using hormone-binding domains.

Pai CC, Schnick J, MacNeill SA, Kearsey SE.

Methods. 2012 Jun;57(2):227-33. doi: 10.1016/j.ymeth.2012.03.032.

PMID:
22504526
12.

Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.

Pai CC, Kuo TF, Mao SJ, Chuang TF, Lin CS, Chu RM.

Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):187-99. doi: 10.1016/j.vetimm.2010.10.013.

PMID:
21051091
13.

GINS inactivation phenotypes reveal two pathways for chromatin association of replicative alpha and epsilon DNA polymerases in fission yeast.

Pai CC, García I, Wang SW, Cotterill S, Macneill SA, Kearsey SE.

Mol Biol Cell. 2009 Feb;20(4):1213-22. doi: 10.1091/mbc.E08-04-0429.

14.

Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.

Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM.

Cancer Lett. 2008 Dec 18;272(2):285-95. doi: 10.1016/j.canlet.2008.07.016.

PMID:
18760876
15.

Rapid regulation of protein activity in fission yeast.

Bøe CA, Garcia I, Pai CC, Sharom JR, Skjølberg HC, Boye E, Kearsey S, Macneill SA, Tyers MD, Grallert B.

BMC Cell Biol. 2008 May 5;9:23. doi: 10.1186/1471-2121-9-23.

17.

Hepatic cerebrospinal fluid pseudocyst: a case report and review of the literature.

Hsieh CT, Pai CC, Tsai TH, Chiang YH, Su YH.

Neurol India. 2006 Mar;54(1):86-8.

18.

Remarkably diastereoselective synthesis of a chiral biphenyl diphosphine ligand and its application in asymmetric hydrogenation.

Qiu L, Wu J, Chan S, Au-Yeung TT, Ji JX, Guo R, Pai CC, Zhou Z, Li X, Fan QH, Chan AS.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5815-20.

19.

Synthesis of novel diastereomeric diphosphine ligands and their applications in asymmetric hydrogenation reactions.

Qiu L, Qi J, Pai CC, Chan S, Zhou Z, Choi MC, Chan AS.

Org Lett. 2002 Dec 26;4(26):4599-602.

PMID:
12489939
20.
Items per page

Supplemental Content

Support Center